(Q40330305)

English

ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through beta1 integrin-dependent activation of PI3-kinase

scientific article published on 27 January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through beta1 integrin-dependent activation of PI3-kinase (English)

1 reference

Europe PubMed Central

19 September 2017

0 references

author name string

P S Hodkinson

1

1 reference

Europe PubMed Central

19 September 2017

T Elliott

2

1 reference

Europe PubMed Central

19 September 2017

W S Wong

3

1 reference

Europe PubMed Central

19 September 2017

R C Rintoul

4

1 reference

Europe PubMed Central

19 September 2017

A C Mackinnon

5

1 reference

Europe PubMed Central

19 September 2017

C Haslett

6

1 reference

Europe PubMed Central

19 September 2017

T Sethi

7

1 reference

Europe PubMed Central

19 September 2017

publication date

27 January 2006

1 reference

Europe PubMed Central

19 September 2017

Cell Death & Differentiation

1 reference

Europe PubMed Central

19 September 2017

13

1 reference

Europe PubMed Central

19 September 2017

1776-1788

1 reference

Europe PubMed Central

19 September 2017

10

1 reference

Europe PubMed Central

19 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.cdd.4401849

0 references

Integrins and extracellular matrix: a novel mechanism of multidrug resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

Cell migration: integrating signals from front to back

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

Stromal extracellular matrix reduces chemotherapy-induced apoptosis in colon cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

Cell-cycle checkpoints and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

Fibronectin, integrins, and growth control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

G1 cell-cycle control and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

Progression through the G1‐phase of the on‐going cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

PI 3-kinase, Akt and cell survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a beta 1 integrin viability signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

Cell-extracellular matrix interactions stimulate the AP-1 transcription factor in an integrin-linked kinase- and glycogen synthase kinase 3-dependent manner

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

Anchorage dependence, integrins, and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

Reduction in drug-induced DNA double-strand breaks associated with beta1 integrin-mediated adhesion correlates with drug resistance in U937 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

Expression of focal adhesion kinase and alpha5 and beta1 integrins in carcinomas and its clinical significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

Genetic evidence for the interactions of cyclin D1 and p27(Kip1) in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

Ectopic expression of cyclin D1 but not cyclin E induces anchorage-independent cell cycle progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

Cell cycle checkpoint evasion and protracted cell cycle arrest in X-irradiated small-cell lung carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

The cell cycle phases of DNA damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

21 January 2018

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

7 January 2021

based on heuristic

inferred from DOI database lookup

Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

7 January 2021

based on heuristic

inferred from DOI database lookup

A link between cyclin A expression and adhesion-dependent cell cycle progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

7 January 2021

based on heuristic

inferred from DOI database lookup

Dependence of cyclin E-CDK2 kinase activity on cell anchorage.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclin-dependent kinases and S phase control in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

7 January 2021

based on heuristic

inferred from DOI database lookup

Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

7 January 2021

based on heuristic

inferred from DOI database lookup

Phosphatidylinositol 3-kinase activity regulates alpha -thrombin-stimulated G1 progression by its effect on cyclin D1 expression and cyclin-dependent kinase 4 activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401849

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CDD.4401849

1 reference

Europe PubMed Central

19 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40330305&oldid=2093706753"